(Q38034186)

English

Risk of cytomegalovirus disease in high-risk liver transplant recipients on valganciclovir prophylaxis: a systematic review and meta-analysis

scientific article published on December 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

0 references

Risk of cytomegalovirus disease in high-risk liver transplant recipients on valganciclovir prophylaxis: a systematic review and meta-analysis (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

Cytomegalovirus

0 references

systematic review

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Andre C Kalil

1

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

Cezarina Mindru

2

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

Jean F Botha

3

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

Wendy J Grant

4

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

David F Mercer

5

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

Marco A Olivera

6

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

Megan A McCartan

7

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

Timothy M McCashland

8

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

Alan N Langnas

9

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

Diana F Florescu

10

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

publication date

1 December 2012

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

Liver Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

18

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

1440-1447

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

Efficacy and safety of valganciclovir vs. oral ganciclovir for prevention of cytomegalovirus disease in solid organ transplant recipients

1 reference

https://api.crossref.org/works/10.1002%2FLT.23530

21 January 2018

Valganciclovir for cytomegalovirus prevention in solid organ transplant patients: an evidence-based reassessment of safety and efficacy

1 reference

https://api.crossref.org/works/10.1002%2FLT.23530

21 January 2018

Cytomegalovirus viremia in solid organ transplantation: does the initial viral load correlate with risk factors and outcomes?

1 reference

https://api.crossref.org/works/10.1002%2FLT.23530

21 January 2018

International consensus guidelines on the management of cytomegalovirus in solid organ transplantation

1 reference

https://api.crossref.org/works/10.1002%2FLT.23530

21 January 2018

Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. QUOROM Group

1 reference

https://api.crossref.org/works/10.1002%2FLT.23530

21 January 2018

Meta-analysis in clinical trials

1 reference

https://api.crossref.org/works/10.1002%2FLT.23530

21 January 2018

Publication and related bias in meta-analysis: power of statistical tests and prevalence in the literature

1 reference

https://api.crossref.org/works/10.1002%2FLT.23530

21 January 2018

Operating characteristics of a rank correlation test for publication bias

1 reference

https://api.crossref.org/works/10.1002%2FLT.23530

21 January 2018

Meta-analysis of Observational Studies in Epidemiology: A Proposal for Reporting

1 reference

https://api.crossref.org/works/10.1002%2FLT.23530

21 January 2018

Efficacy and safety of low-dose valganciclovir in the prevention of cytomegalovirus disease in adult liver transplant recipients

1 reference

https://api.crossref.org/works/10.1002%2FLT.23530

21 January 2018

Delayed-onset primary cytomegalovirus disease after liver transplantation

1 reference

https://api.crossref.org/works/10.1002%2FLT.23530

21 January 2018

Oral ganciclovir versus valganciclovir for cytomegalovirus prophylaxis in high-risk liver transplant recipients

1 reference

https://api.crossref.org/works/10.1002%2FLT.23530

21 January 2018

Increased incidence of cytomegalovirus infection in high-risk liver transplant recipients receiving valganciclovir prophylaxis versus ganciclovir prophylaxis.

1 reference

https://api.crossref.org/works/10.1002%2FLT.23530

21 January 2018

Cytomegalovirus disease in high-risk transplant recipients despite ganciclovir or valganciclovir prophylaxis.

1 reference

https://api.crossref.org/works/10.1002%2FLT.23530

21 January 2018

Does valganciclovir hydrochloride (valcyte) provide effective prophylaxis against cytomegalovirus infection in liver transplant recipients?

1 reference

https://api.crossref.org/works/10.1002%2FLT.23530

21 January 2018

Experience with low-dose valganciclovir prophylaxis in adult liver transplant recipients

1 reference

https://api.crossref.org/works/10.1002%2FLT.23530

21 January 2018

Prophylactic therapy with valgancyclovir in high-risk (cytomegalovirus D+/R-) liver transplant recipients: a single-center experience

1 reference

https://api.crossref.org/works/10.1002%2FLT.23530

21 January 2018

Late-onset CMV disease following CMV prophylaxis

1 reference

https://api.crossref.org/works/10.1002%2FLT.23530

21 January 2018

Late-onset cytomegalovirus disease as a significant complication in solid organ transplant recipients receiving antiviral prophylaxis: a call to heed the mounting evidence

1 reference

https://api.crossref.org/works/10.1002%2FLT.23530

21 January 2018

Meta-analysis: the efficacy of strategies to prevent organ disease by cytomegalovirus in solid organ transplant recipients

1 reference

https://api.crossref.org/works/10.1002%2FLT.23530

21 January 2018

Absence of cytomegalovirus-resistance mutations after valganciclovir prophylaxis, in a prospective multicenter study of solid-organ transplant recipients

1 reference

https://api.crossref.org/works/10.1002%2FLT.23530

21 January 2018

Valacyclovir provides optimum acyclovir exposure for prevention of cytomegalovirus and related outcomes after organ transplantation

1 reference

https://api.crossref.org/works/10.1002%2FLT.23530

21 January 2018

Identifiers

10.1002/LT.23530

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38034186&oldid=1738109326"